Oral squamous cell carcinoma overview, Oral Oncology, vol.45, issue.4-5, pp.301-308, 2009. ,
DOI : 10.1016/j.oraloncology.2009.01.004
Mammalian target of rapamycin, a molecular target in squamous cell ,
Global epidemiology of oral and oropharyngeal cancer, Oral Oncology, vol.45, issue.4-5, pp.309-316, 2009. ,
DOI : 10.1016/j.oraloncology.2008.06.002
Current concepts in management of oral cancer ??? Surgery, Oral Oncology, vol.45, issue.4-5, pp.394-401, 2009. ,
DOI : 10.1016/j.oraloncology.2008.05.017
Dental management of patients irradiated for head and neck cancer, Australian Dental Journal, vol.49, issue.3 Suppl, pp.20-28, 2014. ,
DOI : 10.1111/adj.12134
Oral toxicity produced by chemotherapy: A systematic review, Journal of Clinical and Experimental Dentistry, vol.6, pp.81-90, 2014. ,
DOI : 10.4317/jced.51337
Oral complications of targeted cancer therapies: A narrative literature review, Oral Oncology, vol.47, issue.6, pp.441-448, 2011. ,
DOI : 10.1016/j.oraloncology.2011.03.028
Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer, Oral Oncology, vol.51, issue.7, pp.704-708, 2015. ,
DOI : 10.1016/j.oraloncology.2015.04.012
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck, Cancer, vol.51, issue.24, pp.3940-3951, 2014. ,
DOI : 10.1002/cncr.28965
Dysregulated molecular networks in head and neck carcinogenesis, Oral Oncology, vol.45, issue.4-5, pp.324-234, 2009. ,
DOI : 10.1016/j.oraloncology.2008.07.011
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research, PLoS ONE, vol.32, issue.30 ,
DOI : 10.1371/journal.pone.0026100.t002
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs, International Journal of Biological Sciences, vol.10, issue.7, pp.654-663, 2014. ,
DOI : 10.7150/ijbs.9224
Drug repositioning: identifying and developing new uses for existing drugs, Nature Reviews Drug Discovery, vol.2, issue.8, pp.673-683, 1038. ,
DOI : 10.1038/nrd1468
Molecular targets of luteolin in cancer, European Journal of Cancer Prevention, vol.25, issue.1, 2015. ,
DOI : 10.1097/CEJ.0000000000000128
Signaling Proteins and Pathways Affected by Flavonoids in Leukemia Cells, Nutrition and Cancer, vol.25, issue.2, pp.238-249, 2015. ,
DOI : 10.1080/01635589809514701
Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression, Food Chemistry, vol.141, issue.2, pp.1553-1561, 2013. ,
DOI : 10.1016/j.foodchem.2013.04.077
The antitumor activities of flavonoids, In Vivo, vol.19, pp.895-909, 2005. ,
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy, Current Cancer Drug Targets, vol.8, issue.7, pp.634-646, 2008. ,
DOI : 10.2174/156800908786241050
Anti-carcinogenic Effects of the Flavonoid Luteolin, Molecules, vol.13, issue.12, pp.2628-2651, 2008. ,
DOI : 10.3390/molecules13102628
Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities, Cancer and Metastasis Reviews, vol.281, issue.1-2, pp.323-351 ,
DOI : 10.1007/s10555-012-9347-y
Luteolin Induces Apoptosis in BE Colorectal Cancer Cells by Downregulating Calpain, UHRF1, and DNMT1 Expressions, Nutrition and Cancer, vol.137, issue.7, pp.1220-1227, 2014. ,
DOI : 10.1007/s11010-008-9749-x
Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids, Nutrition and Cancer, vol.41, issue.6, pp.800-809, 2008. ,
DOI : 10.1080/01635580802100851
Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2, PLoS ONE, vol.7, issue.9 ,
DOI : 10.1371/journal.pone.0045562.t001
Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation, Journal of Cell Science, vol.125, issue.17, pp.4137-4146, 2012. ,
DOI : 10.1242/jcs.108282
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints, Annual Review of Biochemistry, vol.73, issue.1, pp.39-85, 2004. ,
DOI : 10.1146/annurev.biochem.73.011303.073723
Enhanced Anti-tumor Activity by the Combination of the Natural Compounds (-)-Epigallocatechin-3-gallate and Luteolin: POTENTIAL ROLE OF p53, Journal of Biological Chemistry, vol.285, issue.45, pp.34557-34565, 2010. ,
DOI : 10.1074/jbc.M110.141135
Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity, Cancer Prevention Research, vol.7, issue.1, pp.65-73, 2014. ,
DOI : 10.1158/1940-6207.CAPR-13-0230
Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells, Biochem Pharmacol, vol.66, pp.2075-2088, 2003. ,
Autophagy Inhibitor Chloroquine Enhanced the Cell Death Inducing Effect of the Flavonoid Luteolin in Metastatic Squamous Cell Carcinoma Cells, PLoS ONE, vol.49, issue.10 ,
DOI : 10.1371/journal.pone.0048264.g005
Luteolin Induces Apoptosis in Oral Squamous Cancer Cells, Journal of Dental Research, vol.87, issue.4, pp.401-406, 2008. ,
DOI : 10.1177/154405910808700413
Structure???Function Relationship of Thiazolide-Induced Apoptosis in Colorectal Tumor Cells, ACS Chemical Biology, vol.9, issue.7, pp.1520-1527, 2014. ,
DOI : 10.1021/cb500209a
-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells, International Journal of Cancer, vol.97, issue.8, pp.1797-1806, 2008. ,
DOI : 10.1002/ijc.23755
URL : https://hal.archives-ouvertes.fr/hal-00408926
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer, Molecular Cancer Therapeutics, vol.14, issue.6, pp.1504-1516 ,
DOI : 10.1158/1535-7163.MCT-14-0792
Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase???Bim axis and reveals glutathione-S-transferase P1 as Achilles??? heel, Oncogene, vol.60, issue.37, pp.4095-4106575, 2011. ,
DOI : 10.1038/nrm2308
A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide, Molecular Cancer Therapeutics, vol.12, issue.9, pp.1896-1905 ,
DOI : 10.1158/1535-7163.MCT-12-1243
Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis, Nephrology Dialysis Transplantation, vol.26, issue.3, pp.814-822, 2011. ,
DOI : 10.1093/ndt/gfq528
Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer, Head & Neck, vol.16, issue.suppl, 2015. ,
DOI : 10.1002/hed.24125
Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro, Food and Chemical Toxicology, vol.60, pp.83-91, 2013. ,
DOI : 10.1016/j.fct.2013.07.036
Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization, Molecular Cancer Therapeutics, vol.6, issue.4, pp.1338-1347, 2007. ,
DOI : 10.1158/1535-7163.MCT-06-0638
Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway, Asian Pacific Journal of Cancer Prevention, vol.15, issue.6, pp.2911-2916, 2014. ,
DOI : 10.7314/APJCP.2014.15.6.2911
Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells, The Journal of Steroid Biochemistry and Molecular Biology, vol.122, issue.4, pp.219-231, 2010. ,
DOI : 10.1016/j.jsbmb.2010.06.006
Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630, PLoS ONE, vol.98, issue.6 ,
DOI : 10.1371/journal.pone.0100124.s009
Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays, International Journal of Molecular Medicine, vol.22, issue.4, pp.433-439, 2008. ,
DOI : 10.3892/ijmm_00000039
Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line, Molecular and Cellular Biochemistry, vol.7, issue.Suppl 3, pp.125-132, 2008. ,
DOI : 10.1007/s11010-008-9749-x
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo, Biochemical and Biophysical Research Communications, vol.447, issue.4, pp.602-608, 2014. ,
DOI : 10.1016/j.bbrc.2014.04.039
Luteolin is effective in the non-small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance, British Journal of Pharmacology, vol.56, issue.11, pp.2842-2853, 2014. ,
DOI : 10.1111/bph.12610
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies, Molecular Cancer Therapeutics, vol.7, issue.9, pp.2955-2966, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0492
Analysis of P53 mutation and invasion front grading in oral squamous cell carcinomas, Journal of Huazhong University of Science and Technology [Medical Sciences], vol.34, issue.10, pp.525-529, 2010. ,
DOI : 10.1007/s11596-010-0462-0
mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma, Anticancer Res, vol.18, pp.53-2031, 1998. ,
Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma, BMC Oral Health, vol.52, issue.1, 2015. ,
DOI : 10.1371/journal.pone.0003360
Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma, Oral Oncology, vol.39, issue.2, pp.163-169, 2003. ,
DOI : 10.1016/S1368-8375(02)00064-7
P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure, Tumori, vol.91, pp.346-350, 2005. ,
p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival, Journal of Cranio-Maxillofacial Surgery, vol.33, issue.5, pp.53-342, 2005. ,
DOI : 10.1016/j.jcms.2005.05.004
Protective effects of Ursolic acid and Luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.692, issue.1-2, 2010. ,
DOI : 10.1016/j.mrfmmm.2010.07.004